Back to Search
Start Over
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
- Source :
-
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2017 Jul 01; Vol. 98 (3), pp. 511-520. Date of Electronic Publication: 2016 Sep 26. - Publication Year :
- 2017
-
Abstract
- Purpose: Many technological and methodical advances have made stereotactic body radiotherapy (SBRT) more accurate and more efficient during the last years. This study aims to investigate whether experience in SBRT and technological innovations also translated into improved local control (LC) and overall survival (OS).<br />Methods and Materials: A database of 700 patients treated with SBRT for lung metastases in 20 German centers between 1997 and 2014 was used for analysis. It was the aim of this study to investigate the impact of fluorodeoxyglucose positron-emission tomography (FDG-PET) staging, biopsy confirmation, image guidance, immobilization, and dose calculation algorithm, as well as the influence of SBRT experience, on LC and OS.<br />Results: Median follow-up time was 14.3 months (range, 0-131.9 months), with 2-year LC and OS of 81.2% (95% confidence interval [CI] 75.8%-85.7%) and 54.4% (95% CI 50.2%-59.0%), respectively. In multivariate analysis, all treatment technologies except FDG-PET staging did not significantly influence outcome. Patients who received pre-SBRT FDG-PET staging showed superior 1- and 2-year OS of 82.7% (95% CI 77.4%-88.6%) and 64.8% (95% CI 57.5%-73.3%), compared with patients without FDG-PET staging resulting in 1- and 2-year OS rates of 72.8% (95% CI 67.4%-78.8%) and 52.6% (95% CI 46.0%-60.4%), respectively (P=.012). Experience with SBRT was identified as the main prognostic factor for LC: institutions with higher SBRT experience (patients treated with SBRT within the last 2 years of the inclusion period) showed superior LC compared with less-experienced centers (P≤.001). Experience with SBRT within the last 2 years was independent from known prognostic factors for LC.<br />Conclusion: Investigated technological and methodical advancements other than FDG-PET staging before SBRT did not significantly improve outcome in SBRT for pulmonary metastases. In contrast, LC was superior with increasing SBRT experience of the individual center.<br /> (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Algorithms
Analysis of Variance
Child
Databases, Factual
Dose Fractionation, Radiation
Female
Fluorodeoxyglucose F18
Follow-Up Studies
Germany
Humans
Immobilization
Inventions
Lung Neoplasms diagnostic imaging
Lung Neoplasms mortality
Male
Middle Aged
Neoplasm Staging
Positron-Emission Tomography methods
Prognosis
Radiopharmaceuticals
Radiotherapy Dosage
Radiotherapy, Image-Guided methods
Treatment Outcome
Young Adult
Cancer Care Facilities standards
Lung Neoplasms radiotherapy
Lung Neoplasms secondary
Radiosurgery methods
Subjects
Details
- Language :
- English
- ISSN :
- 1879-355X
- Volume :
- 98
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- International journal of radiation oncology, biology, physics
- Publication Type :
- Academic Journal
- Accession number :
- 27843031
- Full Text :
- https://doi.org/10.1016/j.ijrobp.2016.09.026